Rezolute Share Price

Rezolute Share Price

NASDAQ: RZLT | Small Cap | Healthcare
$4.26
+$0.24 (5.97%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Rezolute Stock Performance

Open
$3.92
Prev. Close
$4.02
Circuit Range
N/A
Day Range
$3.92 - $4.29
Year Range
$1.07 - $11.15
Volume
1,18,647
Average Traded
$4.12

Rezolute Share Price Today

As of 19 November 2026, Rezolute, Inc. (NV)'s share price is $4.26. The stock opened at $3.92, compared to its previous close of $4.02. During today's trading session, Rezolute, Inc. (NV)'s share price traded between $3.92 and $4.29, with an average price of $4.11. Over the past 52 weeks, the stock has recorded a high of $11.15 and a low of $1.07. In terms of performance, Rezolute, Inc. (NV)'s share price has risen by 28.70% over the last six months and is down 56.11% on a year-on-year basis.

Rezolute Share Price Chart

Line chart of the Rezolute price trend over the selected period. The price rose overall, ranging from 3.92 to 4.29, ending at 4.26.
$3.92$4.29
L
Show Current Price
H

Rezolute Stock Fundamentals & Key Indicators

Market Cap
$323.76M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.81
Revenue (TTM)
$0.00
Return On Equity (TTM)
-90.66%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
18.80%

Rezolute Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$22.77-$16.17-$20.49-$18.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A28.99%-26.72%9.76%

Rezolute Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$51.79-$68.46-$74.41-$77.59
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.19%-8.69%-4.27%

Rezolute Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets2.344.354.0818.81
Current Assets110.51171.15128.65104.91
Total Assets112.85175.49132.74123.72
Non Current Liabilities0.741.452.132.35
Current Liabilities11.4211.919.615.2
Total Liabilities12.1613.3611.737.55
Shareholders' Equity100.69162.13121.0116.17

Rezolute Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-64.64-69.08-57.37-44.48
Investing-21.1-14.5448.7-101.46
Financing2.24107.3363.0311.57

Corporate Actions

Split
Ex-date: 13 Oct 2020

About Rezolute

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Rezolute Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.00
$4.25
+7.45%
Oct 2026
$4.12
$3.96
-4.69%
Sep 2026
$4.67
$4.16
-16.31%
Aug 2026
$4.60
$4.96
+4.97%
Jul 2026
$5.28
$4.73
-8.95%
Jun 2026
$3.27
$5.20
+56.95%
May 2026
$3.17
$3.31
+3.44%
Apr 2026
$3.14
$3.20
+5.26%
Mar 2026
$3.04
$3.04
-5.30%
Feb 2026
$3.28
$3.21
-3.75%
Jan 2026
$2.34
$3.33
+41.01%
Dec 2025
$9.58
$2.37
-75.63%

Rezolute Share Price FAQs